首页 | 本学科首页   官方微博 | 高级检索  
     

肝移植术后多重耐药菌感染危险因素的单中心临床研究
引用本文:方翊天, 吴若林, 黄帆, 等. 肝移植术后多重耐药菌感染危险因素的单中心临床研究[J]. 器官移植, 2021, 12(2): 197-202. doi: 10.3969/j.issn.1674-7445.2021.02.010
作者姓名:方翊天  吴若林  黄帆  王国斌  冯丽娟  余孝俊  侯刘进  叶征辉  耿小平  赵红川
作者单位:230022 合肥,安徽医科大学第一附属医院器官移植中心
基金项目:安徽省高等学校自然科学研究重点项目
摘    要:目的  分析肝移植术后发生多重耐药菌(MDRO)感染的危险因素。方法  回顾性分析77例肝移植受者的临床资料,根据是否发生MDRO感染分为非MDRO感染组(51例)及MDRO感染组(26例)。总结肝移植受者术后MDRO的感染率和菌株分布情况;分析肝移植受者术后发生MDRO感染的危险因素;比较两组受者的预后情况。结果  肝移植术后MDRO感染率为34%(26/77),主要为耐碳青霉烯类MDRO感染,主要感染部位为肺部、腹腔和切口。单因素分析提示术后气管插管≥48 h、重症监护室(ICU)入住时间≥72 h、住院时间≥30 d、再次手术、持续性肾脏替代治疗(CRRT)和他克莫司(Tac)血药浓度≥15 ng/mL是肝移植术后发生MDRO感染的危险因素。Cox回归分析提示术后气管插管≥48 h、再次手术、CRRT和Tac血药浓度≥15 ng/mL是肝移植术后发生MDRO感染的独立危险因素。MDRO感染组病死率高于非MDRO感染组[31%(8/26)比10%(5/51),P=0.01]。结论  术后气管插管≥48 h、再次手术、CRRT和Tac血药浓度≥15 ng/mL会增加肝移植术后MDRO感染的风险,影响受者的预后。

关 键 词:肝移植   多重耐药菌   感染   持续性肾脏替代治疗   耐碳青霉烯类肺炎克雷伯菌   革兰阳性菌   革兰阴性菌   脓毒症
收稿时间:2020-10-25

Risk factors of multi-drug resistant organism infection after liver transplantation: a single-center clinical trial
Fang Yitian, Wu Ruolin, Huang Fan, et al. Risk factors of multi-drug resistant organism infection after liver transplantation: a single-center clinical trial[J]. ORGAN TRANSPLANTATION, 2021, 12(2): 197-202. doi: 10.3969/j.issn.1674-7445.2021.02.010
Authors:Fang Yitian  Wu Ruolin  Huang Fan  Wang Guobin  Feng Lijuan  Yu Xiaojun  Hou Liujin  Ye Zhenghui  Geng Xiaoping  Zhao Hongchuan
Affiliation:Organ Transplantation Center, the First Affiliated Hospital of Anhui Medical University, Hefei 230022, China
Abstract:Objective To analyze the risk factors of multi-drug resistant organism (MDRO) infection after liver transplantation. Methods The clinical data of 77 recipients undergoing liver transplantation were retrospectively analyzed. According to the incidence of MDRO infection, all recipients were divided into the non-MDRO infection group (n=51) and MDRO infection group (n=26). The infection rate and strain distribution of MDRO in liver transplant recipients were summarized. The risk factors of MDRO infection in liver transplant recipients were identified. Clinical prognosis of all recipients was statistically compared between two groups. Results The infection rate of MDRO after liver transplantation was 34% (26/77), mainly carbapenem-resistant MDRO infection. The main sites of infection included lung, abdominal cavity and incision. Univariate analysis showed that postoperative tracheal intubation ≥48 h, length of intensive care unit (ICU) stay ≥72 h, length of hospital stay ≥30 d, re-operation, continuous renal replacement therapy (CRRT) and tacrolimus (Tac) blood concentration ≥15 ng/mL were the risk factors for MDRO infection after liver transplantation. Cox regression analysis indicated that postoperative tracheal intubation≥48 h, re-operation, CRRT and Tac blood concentration ≥15 ng/mL were the independent risk factors for MDRO infection after liver transplantation. The fatality in the MDRO infection group was significantly higher than that in the non-MDRO infection group [31%(8/26) vs. 10%(5/51), P=0.01]. Conclusions Postoperative tracheal intubation ≥48 h, re-operation, CRRT and Tac blood concentration ≥15 ng/mL may increase the risk of MDRO infection after liver transplantation and affect clinical prognosis of the recipients.
Keywords:Liver transplantation  Multi-drug resistant organism  Infection  Continuous renal replacement therapy  Carbapenem-resistant Klebsiella pneumoniae  Gram-positive bacteria  Gram-negative bacteria  Sepsis
本文献已被 万方数据 等数据库收录!
点击此处可从《器官移植》浏览原始摘要信息
点击此处可从《器官移植》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号